selected publications
-
academic article
-
Vargas Ares MBrowne JHardy TMoore EVally HGleeson D. Coverage of Aboriginal and Torres Strait Islander nutrition in the Koori Mail.
Australian and New Zealand Journal of Public Health.
44:180-185.
2020
Full text if available -
Gleeson DO'Brien P. Alcohol labelling rules in free trade agreements: Advancing the industry's interests at the expense of the public's health.
Drug and Alcohol Review.
2020
Full text if available -
Room RGleeson DMiller M. Alcoholic beverages in trade agreements: Industry lobbying and the public health interest.
Drug and Alcohol Review.
2020
Full text if available -
Miller MWilkinson CRoom RO'Brien PTownsend BSchram AGleeson D. Industry submissions on alcohol in the context of Australia's trade and investment agreements: A content and thematic analysis of publicly available documents.
Drug and Alcohol Review.
2020
Full text if available -
Thow AMWaqa GBrowne JPhillips TMcMichael CRavuvu ATutuo JGleeson D. The political economy of restricting marketing to address the double burden of malnutrition: two case studies from Fiji.
Public Health Nutrition.
2020
Full text if available -
Labonté RGleeson DMcNamara CL. USMCA 2.0: A few improvements but far from a 'healthy' trade treaty.
Globalization and Health.
16.
2020
Full text if available -
Townsend BMiller MGleeson D. tackling NCDs: the need to address alcohol industry interference and policy incoherence across sectors; comment on “towards preventing and managing conflict of interest in nutrition policy? an analysis of submissions to a consultation on a draft WHO tool”.
International Journal of Health Policy and Management.
1-4.
2020
Full text if available -
Friel SBaker PThow AMGleeson DTownsend BSchram A. An exposé of the realpolitik of trade negotiations: Implications for population nutrition.
Public Health Nutrition.
22:3083-3091.
2019
Full text if available -
Gleeson DLexchin JLabonté RTownsend BGagnon M-AKohler JForman LShadlen KC. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.
Globalization and Health.
15.
2019
Full text if available -
Gleeson DTownsend BLopert RLexchin JMoir H. Financial costs associated with monopolies on biologic medicines in Australia.
Australian Health Review.
31:36-42.
2019
Full text if available -
Gleeson DForman L. Implications of trade and investment agreements for access to affordable medicines and the right to health.
Canadian human rights yearbook = Annuaire canadien des droits de la personne.
2 (2016-2018):145-154.
2019
-
Phillips TRavuvu AMcMichael CMThow AMBrowne JWaqa GTutuo JGleeson D. Nutrition policy-making in Fiji: working in and around neoliberalisation in the Global South.
Critical Public Health.
2019
Full text if available -
Browne JGleeson DHAdams KMinniecon DHayes FA. Strengthening Aboriginal and Torres Strait Islander health policy: Lessons from a case study of food and nutrition.
Public Health Nutrition.
22:2868-2878.
2019
Full text if available -
Baker PFriel SGleeson DHThow A-MLabonte R. Trade and nutrition policy coherence: a framing analysis and Australian case study.
Public Health Nutrition.
22:2329-2337.
2019
Full text if available -
Labonte REric CGleeson DHMcNamara C. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.
Globalization and Health.
15.
2019
Full text if available -
Schram ARuckert AVanDuzer JAFriel SGleeson DThow A-MStuckler DLabonte R. A conceptual framework for investigating the impacts of international trade and investment agreements on noncommunicable disease risk factors.
Health Policy and Planning.
33:123-136.
2018
Full text if available -
Kumar MGleeson DBarraclough S. Australia's Health Star Rating policy process: Lessons for global policy-making in front-of-pack nutrition labelling.
Nutrition and Dietetics.
75:193-199.
2018
Full text if available -
Browne JGleeson DAdams KAtkinson PHayes R. Coverage of Aboriginal and Torres Strait Islander nutrition in major Australian newspapers, 1996-2015.
Australian and New Zealand Journal of Public Health.
42:277-283.
2018
Full text if available -
Browne JAdams KAtkinson PGleeson DHayes R. Food and nutrition programs for Aboriginal and Torres Strait Islander Australians: an overview of systematic reviews.
Australian Health Review.
42:689-697.
2018
Full text if available -
Townsend BGleeson DLopert R. Japan's emerging role in the global pharmaceutical intellectual property regime: A tale of two trade agreements.
The Journal of World Intellectual Property.
21:88-103.
2018
Full text if available -
Son KBLopert RGleeson DLee TJ. Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States.
Globalization and Health.
14.
2018
Full text if available -
de Leeuw EBrowne JGleeson D. Overlaying structure and frames in policy networks to enable effective boundary spanning.
Evidence and Policy: a journal of research, debate and practice.
14:537-547.
2018
Full text if available -
Moir HVJTenni BGleeson DLopert R. The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam.
Global Public Health.
13:400-413.
2018
Full text if available -
Gleeson DLexchin JLopert RKilic B. The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries.
Global Social Policy.
18:7-27.
2018
Full text if available -
Browne Jde Leeuw EGleeson DAdams KAtkinson PHayes R. A network approach to policy framing: A case study of the National Aboriginal and Torres Strait Islander Health Plan..
Social science & medicine. Medical psychology & medical sociology.
172:10-18.
2017
Full text if available -
Thow AMGleeson D. Advancing public health on the changing global trade and investment agenda. Comment on "The Trans-Pacific Partnership : Is It Everything We Feared for Health?".
International Journal of Health Policy and Management.
6:295-298.
2017
Full text if available -
O'Brien PGleeson DRoom RWilkinson C. Marginalising health information: implications of the trans-pacific partnership agreement for alcohol labelling.
Melbourne University Law Review.
41:341-391.
2017
-
Ruckert ASchram ALabonte RFriel SGleeson DThow A-M. Policy coherence, health and the sustainable development goals: a health impact assessment of the Trans-Pacific Partnership.
Critical Public Health.
27:86-96.
2017
Full text if available -
Barraclough SGleeson D. Why Packaging Is Commercially Vital for Tobacco Corporations: What British American Tobacco Companies in Asia Tell Their Shareholders.
Asia-Pacific Journal of Public Health.
29:132-139.
2017
Full text if available -
Townsend BGleeson DLopert R. Pharma's next frontier? New threats to public health in the Regional Comprehensive Economic Partnership agreement.
Australian and New Zealand Journal of Public Health.
40:5-6.
2016
Full text if available -
Gleeson DDwyer JLin VLegge DHughes A. Can learning sets help policy managers with their wicked problems?.
Health Services Management Research.
29:2-9.
2016
Full text if available -
Hirono KHaigh FGleeson DHarris PThow AMFriel S. Is health impact assessment useful in the context of trade negotiations? A case study of the Trans Pacific Partnership Agreement.
BMJ Open.
6.
2016
Full text if available -
Neuwelt PMGleeson DMannering B. Patently obvious: a public health analysis of pharmaceutical industry statements on the Trans-Pacific Partnership international trade agreement.
Critical Public Health.
26:159-172.
2016
Full text if available -
Friel SPonnamperuma SSchram AGleeson DKay AThow A-MLabonte R. Shaping the discourse: What has the food industry been lobbying for in the Trans Pacific Partnership trade agreement and what are the implications for dietary health?.
Critical Public Health.
26:518-529.
2016
Full text if available -
Townsend BGleeson DLopert R. The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines.
Asia-Pacific Journal of Public Health.
28:682-693.
2016
Full text if available -
Lexchin JGleeson D. The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia.
International Journal of Health Services.
46:597-613.
2016
Full text if available -
Thow AMTGleeson DHFriel S. What doctors should know about the Trans‐Pacific Partnership Agreement.
Medical Journal of Australia.
202:165-166.
2015
Full text if available -
Freeman JKeating GMonasterio ENeuwelt PGleeson D. Call for transparency in new generation trade deals.
Lancet.
385:604-605.
2015
Full text if available -
Gleeson DHMoir HLopert R. Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement.
Medical Journal of Australia.
202:306-308.
2015
Full text if available -
Hughes AGleeson DLegge DLin V. Governance and policy capacity in health development and implementation in Australia.
Policy and Society.
34:229-245.
2015
Full text if available -
Wyber RGleeson D. Treating trade: the case for clinical engagement with regional trade agreements.
The Lancet Diabetes and Endocrinology.
3:400-402.
2015
Full text if available -
Legge DGleeson DH. Unpacking "Health Reform" and "Policy Capacity": Comment on "Health Reform Requires Policy Capacity"..
International Journal of Health Policy and Management.
4:703-705.
2015
Full text if available -
Thow AMSnowdon WLabonte RGleeson DStuckler DHattersley LSchram AKay AFriel S. Will the next generation of preferential trade and investment agreements undermine prevention of noncommunicable diseases? a prospective policy analysis of the Trans Pacific Partnership Agreement.
Health Policy.
119:88-96.
2015
Full text if available -
Legge DGGleeson DHLöfgren HTownsend B. Australia’s position on medicines policy in international forums: Intellectual property protection and public health.
Journal of Australian Political Economy.
103-131.
2014
-
Browne JHayes RGleeson D. Aboriginal health policy: is nutrition the "gap' in "Closing the Gap'?.
Australian and New Zealand Journal of Public Health.
38:362-369.
2014
Full text if available -
Gleeson DLopert RReid P. How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand.
Health Policy.
112:227-233.
2013
Full text if available -
O'Brien PLGleeson DH. Retaining our right to regulate alcohol warnings.
Medical Journal of Australia.
199:447-447.
2013
Full text if available -
Gleeson DFriel S. Emerging threats to public health from regional trade agreements.
Lancet.
381:1507-1509.
2013
Full text if available -
Lopert RGleeson D. The High Price of “Free” Trade: U.S. Trade Agreements and Access to Medicines.
Journal of Law, Medicine, and Ethics.
41:199-223.
2013
Full text if available -
Friel SGleeson DThow A-MLabonte RStuckler DKay ASnowdon W. A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement.
Globalization and Health.
9:1-7.
2013
Full text if available -
Gleeson DHTienhaara KSFaunce TA. Challenges to Australia's national health policy from trade and investment agreements.
Medical Journal of Australia.
196:354-356.
2012
Full text if available -
Gleeson DLegge D. Strengthening public health engagement in trade policy: PHAA's policy onTrade Agreements and Health.
Australian and New Zealand Journal of Public Health.
36:7-11.
2012
Full text if available -
Gleeson DHGleeson RBD. The Health of Nations: Towards a New Political Economy.
Australian Health Review.
36:471-471.
2012
Full text if available -
Gleeson DLegge DO'Neill DPfeffer M. Negotiating Tensions in Developing Organizational Policy Capacity: Comparative Lessons to be Drawn.
Journal of Comparative Policy Analysis: research and practice.
13:237-263.
2011
Full text if available -
Gleeson DHLegge DGO'Neill D. Evaluating health policy capacity: Learning from international and Australian experience.
Australia and New Zealand Health Policy.
6:3.
2009
Full text if available -
Legge DGGleeson DHWilson GWright MMcBride TButler PStagoll O. Micro macro integration: Reframing primary healthcare practice and community development in health.
Critical Public Health.
17:171-182.
2007
Full text if available -
Gleeson DBoston V. A System for Program Evaluation in Community Health.
Australian Journal of Primary Health.
5:74-74.
1999
Full text if available
-
Vargas Ares MBrowne JHardy TMoore EVally HGleeson D. Coverage of Aboriginal and Torres Strait Islander nutrition in the Koori Mail.
Australian and New Zealand Journal of Public Health.
44:180-185.
2020
-
book
-
chapter
-
Gleeson DChong S. Social determinants of health on a global scale.
353-381.
2019
-
Gleeson DHNeuwelt PMonasterio ELopert R. How the Transnational Pharmaceutical Industry Pursues its Interests Through International Trade and Investment Agreements: A Case Study of the Trans Pacific Partnership.
223-254.
2017
-
Legge DZhang TGleeson DYang H. Policy Analysis, policy development and policy capacity.
423-437.
2010
-
Legge DZhang TGleeson DWu QYang H. Policy Theory.
409-422.
2010
-
Gleeson DChong S. Social determinants of health on a global scale.
353-381.
2019
-
comment
-
O’Brien PGleeson DRoom RWilkinson C. Commentary on ‘Communicating Messages About Drinking’: Using the ‘Big Legal Guns’ to Block Alcohol Health Warning Labels.
Alcohol and Alcoholism.
333-336.
2018
Full text if available
-
O’Brien PGleeson DRoom RWilkinson C. Commentary on ‘Communicating Messages About Drinking’: Using the ‘Big Legal Guns’ to Block Alcohol Health Warning Labels.
Alcohol and Alcoholism.
333-336.
2018
-
conference paper
-
editorial article
-
Amin‐Korim RLegge DGleeson D. PHAA's Health Equity Policy.
Australian and New Zealand Journal of Public Health.
42:421-423.
2018
Full text if available -
Hirono KGleeson DFreeman B. To what extent does a tobacco carve-out protect public health in the Trans-Pacific Partnership Agreement?.
Public Health Research and Practice.
26.
2016
Full text if available -
Monasterio EGleeson D. The Trans Pacific Partnership Agreement: Exacerbation of inequality for patients with serious mental illness.
Australian and New Zealand Journal of Psychiatry.
48:1077-1080.
2014
Full text if available -
Monasterio EGleeson DH. Pharmaceutical industry behaviour and the Trans Pacific Partnership Agreement..
New Zealand Medical Journal.
127:6-12.
2014
-
Amin‐Korim RLegge DGleeson D. PHAA's Health Equity Policy.
Australian and New Zealand Journal of Public Health.
42:421-423.
2018
-
erratum
-
Labonte RCrosbie EGleeson DMcNamara C. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health (vol 15, pg 35, 2019).
Globalization and Health.
2019
Full text if available
-
Labonte RCrosbie EGleeson DMcNamara C. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health (vol 15, pg 35, 2019).
Globalization and Health.
2019
-
letter
-
Harris PGleeson D. Assessing the impact of the Trans-Pacific Partnership Agreement on the health of Australians [Letter].
Australian and New Zealand Journal of Public Health.
496-496.
2014
Full text if available -
Gleeson DLopert RReid P. Reply by authors [Letter].
Health Policy.
236-237.
2014
Full text if available
-
Harris PGleeson D. Assessing the impact of the Trans-Pacific Partnership Agreement on the health of Australians [Letter].
Australian and New Zealand Journal of Public Health.
496-496.
2014
-
other publication
-
Gleeson DMenkes DB. Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals.
International Journal of Health Policy and Management.
98-100.
2018
Full text if available
-
Gleeson DMenkes DB. Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals.
International Journal of Health Policy and Management.
98-100.
2018
-
report
-
Thrasher RDWirtz VJKaplan WGallagher KPWerk HBaker BBing HGleeson DIslam MDKrishtel PKyle Mda Fonseca EMSampat BShadlen KTrachtenberg DVawda Y. Rethinking Trade Treaties and Access to Medicines: Toward a Policy-Oriented Research Agenda
2019
-
Hirono KHaigh FGleeson DHarris PThow AM. Negotiating Healthy Trade in Australia: Health Impact Assessment of the Proposed Trans-Pacific Partnership Agreement.
1-33.
2015
-
Thrasher RDWirtz VJKaplan WGallagher KPWerk HBaker BBing HGleeson DIslam MDKrishtel PKyle Mda Fonseca EMSampat BShadlen KTrachtenberg DVawda Y. Rethinking Trade Treaties and Access to Medicines: Toward a Policy-Oriented Research Agenda
2019